Bendazac (CAS 20187-55-7) Supplier Information and Product Details

Bendazac is a non-steroidal anti-inflammatory drug (NSAID) used for joint and muscular pain. It has potential as an anti-denaturant drug for cataract and other condensation diseases as it protects proteins from denaturation induced by different agents. Bendazac inhibits the denaturing of proteins and has anti-inflammatory, antinecrotic, choleretic, and antilipidaemic properties.

Frequently Asked Questions about Bendazac

Q: What are the main uses of Bendazac?

A: Bendazac is primarily used as a non-steroidal anti-inflammatory drug (NSAID) for treating joint and muscular pain. It also has potential applications in managing cataracts and other condensation diseases due to its ability to protect proteins from denaturation.

Q: What is the mechanism of action of Bendazac?

A: Bendazac works by inhibiting the denaturation of proteins. This property makes it useful in treating inflammatory conditions and potentially in managing cataracts.

Q: Are there any specific formulations of Bendazac?

A: Yes, Bendazac is available in various forms, including its lysine salt (Bendazac Lysine) and sodium salt. These formulations may have different applications or improved bioavailability.

Q: What is the toxicity profile of Bendazac?

A: Bendazac is considered moderately toxic by ingestion and subcutaneous routes. It's more toxic when administered intravenously or intraperitoneally. The LD50 in mice and rats varies depending on the route of administration, ranging from 304-1200 mg/kg.